Secondary Logo

Journal Logo

March 13, 2018 - Volume 32 - Issue 5
pp: 539-685

A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients

Rodríguez-Gallego, Esther; Gómez, Josep; Pacheco, Yolanda M.; More

AIDS. 32(5):565-573, March 13, 2018.


The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naïve CD4+ T cells

Nicoli, Francesco; Gallerani, Eleonora; Sforza, Fabio; More

AIDS. 32(5):575-581, March 13, 2018.

Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women

Torres, Thiago S.; Harrison, Linda J.; La Rosa, Alberto M.; More

AIDS. 32(5):583-593, March 13, 2018.

Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma

Rubinstein, Paul G.; Moore, Page C.; Rudek, Michelle A.; More

AIDS. 32(5):605-611, March 13, 2018.

Changes in insulin sensitivity over time and associated factors in HIV-infected adolescents

Geffner, Mitchell E.; Patel, Kunjal; Jacobson, Denise L.; More

AIDS. 32(5):613-622, March 13, 2018.


Impact of early antiretroviral therapy eligibility on HIV acquisition: household-level evidence from rural South Africa

Oldenburg, Catherine E.; Bor, Jacob; Harling, Guy; More

AIDS. 32(5):635-643, March 13, 2018.

Effect of HIV self-testing on the number of sexual partners among female sex workers in Zambia

Oldenburg, Catherine E.; Chanda, Michael M.; Ortblad, Katrina F.; More

AIDS. 32(5):645-652, March 13, 2018.

Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy

Willis, Sarah J.; Cole, Stephen R.; Westreich, Daniel; More

AIDS. 32(5):653-661, March 13, 2018.